| OSMYX | TCMIX | OSMYX / TCMIX | |
| Total Expense Ratio | 1.13 | 1.05 | 108% |
| Annual Report Gross Expense Ratio | 1.13 | 1.11 | 102% |
| Fund Existence | 20 years | 13 years | - |
| Gain YTD | 12.901 | 25.106 | 51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.66B | 117M | 2,272% |
| Annual Yield % from dividends | 1.50 | 2.39 | 63% |
| Returns for 1 year | 1.93 | 22.26 | 9% |
| Returns for 3 years | 7.69 | 40.92 | 19% |
| Returns for 5 years | -24.52 | 10.58 | -232% |
| Returns for 10 years | 18.05 | 54.42 | 33% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WIAEX | 38.25 | 0.26 | +0.68% |
| Wasatch Small Cap Growth Institutional | |||
| DRTCX | 21.28 | 0.09 | +0.42% |
| BNY Mellon Sust US Equity I | |||
| WRCGX | 6.47 | N/A | N/A |
| William Blair China Growth R6 | |||
| VSFAX | 24.56 | -0.05 | -0.20% |
| Federated Hermes Clover Small Value A | |||
| JFNIX | 81.94 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences I | |||